Conflict of interest declaration: Robert West

Roles in: Tobacco Addiction Group

1. In the past three years have you accepted the following from an organisation that may gain or lose financially from the publication of reviews by your review group in the Cochrane Database of Systematic Reviews (CDSR)?

a) Reimbursement for attending a conference or symposium (including travel, accommodation and/or hospitality)?
Yes - I have received travel funding from Pfizer who market varenicline for smoking cessation, and GSK and J&J who manufacture nicotine replacement products

b) Fees for speaking?
Yes - I have received fees from Pfizer who market varenicline for smoking cessation, and GSK and J&J who manufacture nicotine replacement products

c) Fees for organising education?
No

d) Funds for research?
Yes - I have received research funding from Pfizer who market varenicline for smoking cessation, and GSK and J&J who manufacture nicotine replacement products

e) Funds for a member of staff?
No

f) Fees for consulting?
Yes - I have received consulting fees from Pfizer who market varenicline for smoking cessation, and GSK and J&J who manufacture nicotine replacement products

g) Royalty payments?
Yes - I receive royalties from a book 'The SmokeFree Formula' and another 'Theory of Addiction'

2. In the past three years have you or your spouse/partner been employed by an organization that may in any way gain or lose financially from the publication of reviews by your review group in the CDSR?
No

3. Do you own stocks or shares in companies that may gain or lose financially from the publication of reviews by your review group in the CDSR?
No

4. Do you hold any patents for products that that may lead you to gain or lose financially from the publication of reviews by your review group in the CDSR?
No

5. Do you have any other competing interests (financial or non-financial)?
Yes - I am an unpaid advisor to the UK's National Centre for Smoking Cessation and Training.